Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature
Author(s) -
Rikke Bech,
Line Kibsgaard,
Christian Vestergaard
Publication year - 2018
Publication title -
frontiers in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.388
H-Index - 39
ISSN - 2296-858X
DOI - 10.3389/fmed.2018.00238
Subject(s) - bullous pemphigoid , medicine , dermatology , pemphigoid , disease , immunology , antibody , pathology
Bullous Pemphigoid is an autoimmune skin blistering disease. It is caused by deposition of auto antibodies along the dermal-epidermal border leading to inflammation. The antibodies are directed against anchoring filaments in the epidermis, but these antigens are also present in the neurological tissues and this has led to speculation of an association between multiple sclerosis and bullous pemphigoid. Additionally recent epidemiological studies have pointed at an increased risk of cardio-vascualr diseases and an increased moratality among the patients with bullous pemphigoid. In this mini review we present the recent findings in this area and as well as the treatment strategies when comorbidities are taken into consideration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom